Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Sciences, Icon Ink Biomarker Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Irish biotech and pharmaceutical services firm Icon and Proteome Sciences have agreed to collaborate to offer a biomarker discovery solution to assess new candidate drugs, Icon said today.

Under the agreement, Proteome Sciences' PS Biomarker Services business will expand Icon's biomarker solution to include an integrated suite of labeling, separation, and mass spectrometry tools for use in peptide profiling in complex biological materials. Icon said it is already working with Proteome Sciences under a joint project to develop a mass spectrometry assay for a biomarker for a pharmaceutical development company.

Icon's VP of Biomarker Lab Services, John Allison, said in a statement that the partnership complement's the firm's "portfolio of biomarker development and analysis services to help sponsor identify, implement, and interpret the right biomarkers to inform their pre-clinical and clinical drug development."

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.